What is Adalimumab?

Category: Prescription Drugs

Most popular types: Humira Humira Pen Humira Pen Psoriasis Starter Package Show all

false

Adalimumab is an injectable product that can be used to treat a variety of autoimmune conditions including: rheumatoid arthritis, juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn's disease, ulcerative colitis, and plaque psoriasis.

Reported purpose & perceived effectiveness
Purpose Patients Evaluations Perceived Effectiveness
Rheumatoid arthritis 332 187
Crohn's disease 215 105
Psoriasis 112 48
Ankylosing spondylitis 84 45
Psoriatic arthritis 73 53
Ulcerative colitis 25 19

Show all 48 reasons taken


  • Major
  • Moderate
  • Slight
  • None
  • Can't tell

Side effects

Side effects as an overall problem

Side effects as an overall problem
Severity Evaluations Percentage
Severe 55
Moderate 78
Mild 107
None 183

Commonly reported side effects and conditions associated with Adalimumab

Side effect Patients Percentage
Fatigue 16
Headaches 16
Nausea 16
Weakened immune system 15
Injection site pain 10
Injection site itching 9

Show all 144 reported side effects

Dosages

Based on patients currently taking Adalimumab

Dosage Patients Percentage
40 mg/0.8 mL every other week 13
40 mg every other week 12
1 mixed every other week 7
100 mg every other week 7
50 mg every other week 5
40 mg/0.8 mL weekly 3
40 mg weekly 3
1 other every other week 2
1 mixed weekly 2
20 mg/0.4 mL every other week 2

See all 16 dosages

Why patients stopped taking Adalimumab

Multiple reasons could be selected

Reason Patients Percentage
Did not seem to work 176
Side effects too severe 95
Doctor's advice 78
Other 37
Expense 15
Change in health plan coverage 11
Personal research 8
Course of treatment ended 7
See all 297 patients who've stopped taking Adalimumab

Duration

Currently taking Adalimumab

Duration Patients Percentage
6 months - 1 year 4
1 - 2 years 10
2 - 5 years 29
5 - 10 years 11
10 years or more 10

Stopped taking Adalimumab

Duration Patients Percentage
Less than 1 month 53
1 - 6 months 67
6 months - 1 year 72
1 - 2 years 44
2 - 5 years 48
5 - 10 years 9
10 years or more 6
Adherence
Adherence Evaluations Percentage
Always 352
Usually 45
Sometimes 7
Never taken as prescribed 19
Burden
Burden Evaluations Percentage
Very hard to take 34
Somewhat hard to take 81
A little hard to take 118
Not at all hard to take 190
Cost per month
Cost per month Evaluations Percentage
$200+ 28
$100-199 5
$50-99 16
$25-49 20
< $25 195
Not specified 159

What people switch to and from

Patients started taking Adalimumab after stopping:

Treatment Patients Percentage
Etanercept (Enbrel SureClick) 48
Infliximab (Remicade) 45
Methotrexate (Trexall) 32
Mesalamine (Pentasa) 10
Sulfasalazine (Salazopyrin) 10

Show all 38 treatments patients report switching from

Patients stopped taking Adalimumab and switched to:

Treatment Patients Percentage
Etanercept (Enbrel SureClick) 21
Infliximab (Remicade) 20
Certolizumab (Cimzia) 15
Abatacept (Orencia) 13
Methotrexate (Trexall) 8

Show all 22 treatments patients report switching to

Last updated:

17 patient evaluations for Adalimumab

Nov 1, 2018 (Started Oct 24, 2018)

  • Effectiveness
    Can't tell (for rheumatoid arthritis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    Not at all hard to take
Dosage: 1 other Every Other Week
Advice & Tips: I just started taking this so I cannot really give a good evaluation, but I did notice the burning pain in my spine almost disappear 2 hours after the Dr gave me my first dose. The pain is back in my joints and back. I am waiting for the Insurance to approve my next dose.
Cost: < $25 monthly

  • 0 helpful marks

Aug 21, 2016 (Started Jul 01, 2007)

  • Effectiveness
    None (for rheumatoid arthritis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Cost: < $25 monthly

Jun 30, 2008 (Started Jul 01, 2007)

  • Effectiveness
    None (for rheumatoid arthritis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 50 mg Weekly
Cost: < $25 monthly

  • 0 helpful marks

Jun 15, 2016 (Started Jul 01, 2014)

  • Effectiveness
    Moderate (for ankylosing spondylitis)
  • Side effects
    None
  • Adherence
    Always
  • Burden
    A little hard to take
Dosage: 50 mg Every Other Week
Cost: $25-49 monthly

  • 1 helpful mark
Last updated:
Showing 3 of 17 patient evaluations for Adalimumab